As of May 2024 InfuSystem has a market cap of $0.13 Billion. This makes InfuSystem the world's 7238th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.13 B | -38.58% |
2023 | $0.22 B | 24.53% |
2022 | $0.17 B | -49.14% |
2021 | $0.35 B | -7.52% |
2020 | $0.38 B | 124.77% |
2019 | $0.16 B | 151.83% |
2018 | $67.34 M | 28.53% |
2017 | $52.39 M | -9.36% |
2016 | $57.8 M | -15.08% |
2015 | $68.07 M | -3.12% |
2014 | $70.27 M | 49.53% |
2013 | $46.99 M | 43.7% |
2012 | $32.7 M | -4.39% |
2011 | $34.2 M | -34.95% |
2010 | $52.58 M | 27.58% |
2009 | $41.21 M | 2.01% |
2008 | $40.4 M | -42.13% |
2007 | $69.82 M | -32.94% |
2006 | $0.10 B |
On May 18th, 2024 the market cap of InfuSystem was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Premier PINC | $2.06 B | 1,402.65% | ๐บ๐ธ USA |
DexCom DXCM | $52.23 B | 37,991.81% | ๐บ๐ธ USA |
CorVel Corporation
CRVL | $4.64 B | 3,285.91% | ๐บ๐ธ USA |
Biolase
BIOL | $5.28 M | -96.14% | ๐บ๐ธ USA |